Cornea · 2000 · 51 citations · 21 references
MedicineOphthalmologyOcular ImmunologyOphthalmic PathologyPhotodermatologyCorneal PathologyCorneal PhysiologyCollagen DegradationCollagen Matrix DegradationControl Group DesignMatched Control GroupTear Film BiomarkersTear Film DisordersTear Film Physiology
PURPOSE: Levels of collagen degradation products (telopeptides) in the tear film of patients with keratoconus were measured to study the release of telopeptides in the tears. METHODS: Tear samples were collected from 26 keratoconus patients and 36 age-similar human control subjects. Levels of telopeptides were quantified and compared between the two groups. RESULTS: The telopeptide level in tears from keratoconus patients was 2.5-fold higher than in tears from the control group. The telopeptide concentration was age-dependent in both groups. In tears from young people, telopeptide level was 2-fold higher than in tears from the older people. CONCLUSION: The tear film of patients with keratoconus contains higher levels of telopeptides than those of control subjects. Determination of telopeptide levels in tears could be useful for the follow-up of keratoconus development in patients.
21
Immunoassay for quantifying type I collagen degradation products in urine evaluated
M. Bonde, Per Qvist, Christian Fledelius et al. · Clinical Chemistry · 1994 · 334 citations
Expression of degradative enzymes and protease inhibitors in corneas with keratoconus.
Lili Zhou, Shoichi Sawaguchi, Sally S. Twining et al. · PubMed · 1998 · 220 citations
Medicine, Ophthalmology, Pathology +17